Expression of Jagged1/Notch3 Signaling Pathway and their Relationship with the Tumor Angiogenesis in TNBC

Siliang Xue1, Lang He2, Xiao Zhang3

  • 1Department of Dermatology, West China Hospital, Sichuan University, Chengdu, Sichuan, China.

Abstract

Insights

Jagged1/Notch3 signaling is expressed in triple-negative breast cancer (TNBC). Jagged1 predicts poor prognosis, and Jagged1/Notch3 may be a therapeutic target for TNBC angiogenesis.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Research

Background:

  • The Jagged1/Notch3 signaling pathway is crucial for breast cancer angiogenesis.
  • Its role in triple-negative breast cancer (TNBC) remains largely uncharacterized.
  • This study investigates Jagged1/Notch3 expression and its clinical significance in TNBC.

Purpose of the Study:

  • To determine Jagged1/Notch3 mRNA and protein expression in TNBC.
  • To analyze correlations between Jagged1/Notch3 and clinicopathological features, prognosis, and VEGF.
  • To evaluate Jagged1/Notch3 as a potential therapeutic target in TNBC.

Main Methods:

  • Quantitative real-time PCR (Q-RT-PCR) and Western blotting for mRNA and protein levels.
  • Immunohistochemistry for Jagged1/Notch3, VEGF, and CD34 (microvessel density marker).
  • Statistical analysis to assess correlations and prognostic significance.

Main Results:

  • Jagged1/Notch3 mRNA and protein expression were concordant.
  • Positive Jagged1 expression correlated with poorer disease-free survival (DFS) and overall survival (OS) in TNBC patients.
  • Jagged1 was an independent predictor of OS.
  • VEGF expression correlated positively with microvessel density (MVD).
  • MVD was significantly associated with both Jagged1 and Notch3 expression.
  • Jagged1/Notch3 influenced DFS and OS in TNBC patients with positive VEGF expression.

Conclusions:

  • Jagged1/Notch3 is expressed in TNBC at both mRNA and protein levels.
  • Jagged1 serves as an independent predictor of poor prognosis in TNBC.
  • A potential crosstalk exists between Jagged1/Notch3 and VEGF in TNBC angiogenesis.
  • Jagged1/Notch3 represents a promising signaling pathway and therapeutic target for TNBC progression and neovascularization.

Related Concept Videos

Notch Signaling Pathway03:14

Notch Signaling Pathway

The Notch signaling pathway is a major intracellular signaling pathway that is highly conserved over a broad spectrum of metazoan species. It stands unique from other intracellular signaling mechanisms in animals because notch protein itself acts as the receptor as well as the primary signaling molecule.
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not...
6.7K
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
3.8K
Mechanism of Angiogenesis01:10

Mechanism of Angiogenesis

Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...
7.3K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
5.9K
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
10.7K
Role Of Notch Signalling In Intestinal Stem Cell Renewal01:12

Role Of Notch Signalling In Intestinal Stem Cell Renewal

Notch signaling was first discovered in Drosophila melanogaster, where it is involved in cell lineage differentiation. Notch signaling regulates the maintenance and differentiation of intestinal stem cells or ISCs by controlling the expression of atonal homolog 1 or Atoh1. Atoh1 directs cells to differentiate into secretory cells.
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
2.5K